Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling

Glioblastoma (GBM) is a fatal cancer. Existing therapies do not have significant efficacy for GBM patients. Previous studies have shown that the collagen family is involved in the regulation of the extracellular environment of cancer cells, and these conditions could become an important factor for e...

Full description

Saved in:
Bibliographic Details
Published in:Cell death discovery 2021-10, Vol.7 (1), p.313-313, Article 313
Main Authors: Tsai, Hsing-Fang, Chang, Yu-Chan, Li, Chien-Hsiu, Chan, Ming-Hsien, Chen, Chi-Long, Tsai, Wen-Chiuan, Hsiao, Michael
Format: Article
Language:English
Subjects:
631/67/1857
631/67/1922
631/80/84
Actin
Apoptosis
Biochemistry
Biomedical and Life Sciences
Brain cancer
Cell Biology
Cell Cycle Analysis
Collagen
Collagen (type V)
Extracellular matrix
Filaments
Glioblastoma
Life Sciences
Malignancy
Mesenchyme
Metastases
Patients
Stem Cells
Therapeutic targets
Transcription factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glioblastoma (GBM) is a fatal cancer. Existing therapies do not have significant efficacy for GBM patients. Previous studies have shown that the collagen family is involved in the regulation of the extracellular environment of cancer cells, and these conditions could become an important factor for effective treatment. Therefore, we screened various collagen types and observed that the type V collagen α1 chain (COL5A1) gene plays a pivotal role in GBM. We further examined whether the overexpression of COL5A1 is common in mesenchymal subtypes and is related to the survival rate of GBM patients through several in silico cohorts. In addition, our cohort also showed a consistent trend in COL5A1 protein levels. Most importantly, we validated the cell mobility, metastatic ability and actin polymerization status caused by COL5A1 with two-way models. Based on these results, we established a transcriptomics dataset based on COL5A1. Moreover, PPRC1, GK and ESM1 were predicted by ingenuity pathway analysis (IPA) to be transcription factors or to participate downstream. We investigated the involvement of COL5A1 in extracellular remodeling and the regulation of actin filaments in the metastasis of GBM. Our results indicate that the COL5A1−PPRC1−ESM1 axis may represent a novel therapeutic target in GBM.
ISSN:2058-7716
2058-7716
DOI:10.1038/s41420-021-00661-3